3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
8
Active not recruiting
6
Unknown
4
Recruiting
3
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
5
Tongue Neoplasms
4
Head and Neck Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Squamous Cell
1
Mucositis
1
Mouth Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Glioma
1
Glioblastoma
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Cisplatin
5
Cetuximab
3
Radiotherapy
2
Petrolatum
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
temoporfin
1
talazoparib
1
ruxolitinib
1
peginterferon alfa-2a
1
olaparib
1
fluoromisonidazole
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cedazuridine
1
atezolizumab
1
aldesleukin
1
Vorinostat
1
Sorafenib
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Narrow Band Imaging
1
Interviews as Topic
1
Interleukin-2
1
Gefitinib
1
Decitabine
1
DNA
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Carcinoma, Squamous Cell
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT01491139
2012-05-30
ORCA
University College, London
Phase 1
Withdrawn